Clinical chemistry is the branch of laboratory medicine that analyzes biological fluids, primarily blood and urine, to help diagnose disease, guide treatment, and monitor how well a therapy is working. It covers a remarkably wide range of measurements: blood sugar, cholesterol, liver enzymes, kidney function markers, electrolytes, hormones, drug levels, and tumor markers, among many others.1Frontiers in Medicine. Advancing clinical biochemistry: addressing gaps and driving future innovations If you have ever had routine blood work drawn at a doctor’s office, the bulk of those results came from a clinical chemistry laboratory. The field is far more than just running samples through machines, though, and understanding how it works sheds light on why your doctor orders the tests they do and what the numbers actually mean.
What Gets Measured and Why
A standard chemistry panel includes metabolites like glucose and urea, electrolytes such as sodium, potassium, and chloride, enzymes that leak from damaged organs, and proteins that serve as markers of inflammation or nutritional status. Specialized panels go further: cardiac biomarkers after a suspected heart attack, hormone panels for thyroid or reproductive health, drug concentrations for people on medications with narrow safety margins, and tumor markers for cancer surveillance. Each test is chosen because its result changes a clinical decision, whether that means starting a medication, adjusting a dose, or ordering imaging.
The sheer variety matters because no single number tells the whole story. A high blood glucose reading, for instance, might reflect a stressful hospital stay, steroid medication, or genuine diabetes. Pairing it with a hemoglobin A1c measurement, which reflects average blood sugar over roughly three months, gives a much clearer picture.2PubMed Central. HbA1c: A Review of Analytical and Clinical Aspects The combination of glucose and HbA1c is more useful for screening diabetes than either test alone.3American Journal of Clinical Pathology. Combined utility of Glucose and HbA1C testing for screening diabetes mellitus That complementary logic, using groups of tests rather than single numbers, runs through nearly every corner of the discipline.
Serum, Plasma, and Why the Tube Color Matters
Before a test is run, the blood sample has to be collected in the right kind of tube. You have probably noticed that the tubes your phlebotomist uses have different-colored caps. Those colors indicate different additives, and they determine whether the lab works with serum (the liquid left after blood clots) or plasma (the liquid separated from blood that has been prevented from clotting by an anticoagulant). The distinction sounds technical, but it has real consequences for your results.
For most routine chemistry tests, plasma and serum give clinically equivalent results. A study in dialysis patients found that heparin plasma could be substituted for serum without meaningful differences for the majority of tests. Three exceptions stood out: parathyroid hormone, where a specific anticoagulant called EDTA is preferred; the liver enzyme AST, where the same sample type should be used when tracking trends over time; and glucose, which tends to read lower in plasma than in serum.4PubMed Central. Chemistry Testing on Plasma Versus Serum Samples in Dialysis Patients: Clinical and Quality Improvement Implications
The choice of tube affects more advanced measurements too. Research comparing citrate plasma, EDTA plasma, and serum found that amino acid levels tended to be higher in serum, while citrate plasma showed reduced lipoprotein-related values compared with the other two sample types.5PubMed Central. Serum or Plasma (and Which Plasma), That Is the Question These differences do not usually trip up everyday clinical care, because labs standardize which tube they use for each test. But if you switch hospitals or laboratories and the new facility uses a different tube type, comparing old and new results can be misleading.
Liver Tests and the Art of Pattern Recognition
Liver function panels are among the most commonly ordered chemistry tests, and interpreting them is less about any single enzyme and more about how several enzymes relate to each other. Two aminotransferases, ALT and AST, rise when liver cells are injured. Two other enzymes, ALP and GGT, rise when bile flow is obstructed. By comparing the degree of elevation in ALT and AST against the elevation in ALP, clinicians can distinguish between hepatocellular injury, where the liver cells themselves are damaged, and a cholestatic pattern, where the problem is blocked bile ducts.6PubMed Central. Abnormal liver enzymes: A review for clinicians A mixed pattern falls in between. This pattern recognition approach lets your doctor narrow the possible causes dramatically before ordering any imaging.
The same liver enzymes also show up in unexpected places. AST is found in heart and skeletal muscle, so a gym session or a heart attack can raise it. GGT can be elevated from alcohol use or certain medications without any structural liver disease. That is why labs run panels rather than single tests, and why your doctor considers the pattern, not just whether one number is highlighted in red on the printout.
Heart Failure and Cardiac Biomarkers
Cardiology relies heavily on clinical chemistry for two broad purposes: assessing cardiovascular risk over the long term and diagnosing acute events like heart attacks or heart failure. For chronic risk, the lipid panel has been the workhorse for decades. LDL cholesterol remains the primary target for preventing coronary heart disease, but many people who develop heart disease do not have especially high LDL. Low HDL cholesterol and elevated triglycerides identify additional risk, and looking at the full lipid profile catches more high-risk individuals than LDL alone.7PubMed. Role of lipid and lipoprotein profiles in risk assessment and therapy
More recently, apolipoprotein B (apoB) has gained attention as a way to refine cardiovascular risk assessment beyond the standard panel. ApoB represents the total number of potentially harmful lipoprotein particles in the blood, and an expert consensus now recognizes that measuring it alongside the standard lipid profile adds clinically useful information for guiding treatment decisions.8PubMed Central. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
For acute heart problems, the biomarkers are different. B-type natriuretic peptide (BNP) and its cousin NT-proBNP are the go-to tests for diagnosing and monitoring heart failure. They rise when the heart is under strain and are now being explored as screening tools to catch heart failure before symptoms appear. High-sensitivity troponins, meanwhile, detect tiny amounts of heart-muscle damage and are essential for ruling a heart attack in or out within hours of a patient arriving at the emergency room.9PubMed Central. Biomarkers for the diagnosis and management of heart failure
Electrolytes and Blood Gas Analysis
Electrolytes like sodium, potassium, and chloride are measured constantly in hospital settings because even small imbalances can be dangerous. Potassium is particularly tricky: too high, and the heart can go into a fatal rhythm; too low, and muscles weaken and the heart becomes irritable. Acid-base status, assessed through arterial blood gases, ties directly into electrolyte balance. Assessing the kind of acid-base disturbance a patient has requires knowing the arterial pH, the partial pressure of carbon dioxide, and the bicarbonate level, and potassium balance is often disrupted alongside these changes.10PubMed. Blood-gas analysis and the assessment of acid-base status
Drawing arterial blood is painful and carries a small risk of complications, so clinicians sometimes use central venous blood as an alternative in intensive care. A study of ICU patients showed strong correlations between arterial and central venous measurements for pH, carbon dioxide, bicarbonate, and electrolytes, suggesting the venous route is a reasonable substitute in many situations.11PubMed Central. Central Venous Blood Gas Analysis: An Alternative to Arterial Blood Gas Analysis for pH, PCO2, Bicarbonate, Sodium, Potassium and Chloride in the Intensive Care Unit Patients Knowing that a less invasive sample can give clinically useful answers matters a great deal to patients who might otherwise need repeated arterial punctures during a long ICU stay.
Kidney Function Estimates in Children
Kidney function is typically assessed by estimating the glomerular filtration rate (eGFR), a number that reflects how well the kidneys filter waste. In adults, standard equations using creatinine do a reasonable job. In children, the math is harder because their muscles are still growing, their creatinine levels change with age, and the equations developed for adults do not translate well. A study comparing eGFR equations in Chinese children found that the equations combining creatinine, cystatin C, and blood urea nitrogen came closest to the directly measured filtration rate, with roughly four out of five estimates falling within 30% of the true value.12PubMed. Comparison of eGFR equations for estimating kidney function in Chinese children The broader takeaway is that no single blood marker is enough for pediatric kidney assessment; combining markers gives a more reliable picture.
Children also pose unique challenges for reference ranges. What counts as a “normal” value for a liver enzyme or an electrolyte shifts dramatically from a premature infant to a toddler to a teenager. One study protocol designed to establish age-specific reference ranges for children required collecting samples across 19 distinct age groups, from neonates through each year of life up to 18, plus additional gestational-age groups for premature babies.13BMJ Open. A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol The scale of that effort reveals how granular the biochemistry of childhood really is.
How Instruments Produce the Numbers
Most of the tests described above run on large automated analyzers that use light-based measurement, known broadly as spectrophotometry, or immunoassay techniques that exploit the exquisite specificity of antibodies. Spectrophotometric methods measure how much light a colored reaction product absorbs: the darker the solution, the more of the substance you are looking for. Accuracy depends on the instrument behaving predictably across its measurement range.14PubMed Central. The Role of Spectrophotometric Standards in the Clinical Chemistry Laboratory
Immunoassays dominate hormone testing, therapeutic drug monitoring, and many protein-based measurements. Older enzyme-linked immunoassays (ELISA) have been increasingly supplemented by chemiluminescent immunoassays (CLIA), which offer a wider measurement range, higher sensitivity, faster turnaround, and full automation. Both give similar results for tests like hepatitis B surface-antibody detection, though exact numbers can differ because of variations in calibrators.15PubMed Central. Comparing Assay Performance of ELISA and Chemiluminescence Immunoassay in Detecting Antibodies to Hepatitis B Surface Antigen Chemiluminescent platforms can run large panels of different antibody tests simultaneously in random-access mode, making them the dominant technology in high-throughput labs.16PubMed Central. Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
For analytes where immunoassays struggle with specificity, liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has become indispensable. This technique physically separates molecules from each other and then identifies them by their mass, giving a level of chemical certainty that antibody-based methods cannot always match. Over the past two decades it has grown from a niche research tool into a routine clinical technology used for steroid hormones, vitamins, immunosuppressant drugs, and newborn screening, among other applications.17PubMed Central. LC-MS/MS in the Clinical Laboratory – Where to From Here? In many of these areas it is now considered irreplaceable.18PubMed. After another decade: LC-MS/MS became routine in clinical diagnostics
Automation and the Speed of Results
Modern clinical chemistry labs bear little resemblance to the manual pipetting and test-tube-racking operations of earlier decades. The first practical automated chemistry analyzer was developed in 1956 by Leonard Skeggs, who created the AutoAnalyzer to measure urea, glucose, and calcium. It sold for $3,500 and launched an era of continuous-flow analysis. A discrete-analysis approach followed in 1959 with the Robot Chemist, and centrifugal analyzers arrived in 1968.19PubMed Central. Clinical Chemistry Laboratory Automation in the 21st Century – Amat Victoria curam (Victory loves careful preparation)
Today’s total laboratory automation systems connect every step from sample receipt to result delivery. Tubes are loaded onto a track, sorted, centrifuged, uncapped, routed to the right analyzer, and recapped, all without human hands. This reduces handling errors and improves patient safety, while standardizing turnaround time so that urgent (“stat”) samples no longer need to be singled out and prioritized by hand.20PubMed. The effects of total laboratory automation on the management of a clinical chemistry laboratory. Retrospective analysis of 36 years The result is that a basic metabolic panel ordered from an emergency room can come back in well under an hour.
Quality Control Behind the Scenes
Every result that reaches your doctor passes through an invisible quality-control system. Laboratories run control samples with known concentrations alongside patient samples. If the controls fall outside acceptable limits, the patient results are held and the problem investigated. The rules governing when to accept or reject a run, often called Westgard rules after the statistician who developed them, vary depending on how tightly a particular test needs to be controlled.
Performance is sometimes expressed using sigma metrics, borrowed from manufacturing. A “six sigma” test is so precise and accurate that fewer than three or four results in a million fall outside specifications. In one evaluation at a clinical chemistry reference laboratory, tests like pancreatic amylase, HDL cholesterol, AST, triglycerides, total bilirubin, and ALT all achieved six-sigma performance, meaning they needed only minimal quality-control oversight. Urea, creatinine, and chloride, however, failed to meet even minimal sigma thresholds and required closer monitoring.21PubMed Central. Evaluation of Sigma Metrics and Westgard Rule Selection and Implementation of Internal Quality Control in Clinical Chemistry Reference Laboratory, Ethiopian Public Health Institute That kind of granular assessment means labs can allocate resources where they matter most, watching the fragile tests closely while letting the robust ones run with lighter oversight.
Personalized Reference Intervals
The reference range printed on your lab report, that “normal” range in parentheses, comes from population studies of healthy individuals. But individuals vary tremendously. Your personal normal potassium, for instance, might sit at the low end of the population range, so a value in the middle might represent a meaningful rise for you even though it is technically “normal.” Research into biological variation has shown that for roughly half of commonly measured chemistry and blood-count analytes, the population-based reference range is too wide to detect clinically important changes in an individual.22PubMed. Annual biological variation and personalized reference intervals of clinical chemistry and hematology analytes
A growing body of work focuses on personalized reference intervals derived from a person’s own previous results combined with published biological variation data. The idea is simple: if you have had the same test done three or four times when you were healthy, those past results can anchor a range specific to you. This approach has been modeled formally and is gaining traction, especially in the context of annual health assessments where serial data accumulate naturally.23Clinical Chemistry. Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation Newer models can even generate more robust population-based reference intervals using fewer healthy volunteers than traditional methods require, provided reliable biological variation data are available.24PubMed. Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data
Point-of-Care Testing
Not every chemistry result needs to wait for a trip to the central lab. Point-of-care testing (POCT) brings miniaturized analyzers to the bedside, the operating room, or even a general practitioner’s office. The speed advantage is dramatic: one study found that POCT delivered results in an average of about 8 minutes from blood draw, compared with roughly an hour for a central lab, and even longer before the physician actually saw the results.25PubMed. Point-of-care versus central laboratory testing: an economic analysis in an academic medical center In that study, physicians estimated that the faster turnaround would have changed the timing of treatment for nearly one in five patients.
Speed comes with trade-offs, however. Electrolyte results from point-of-care devices generally agree well with central lab values, but hemoglobin and hematocrit measurements are less reliable, with POCT tending to overestimate hemoglobin and underestimate hematocrit, particularly during massive transfusions. Lactate measurements also lose precision at higher concentrations, exactly the range where accuracy matters most in critically ill patients.26PubMed. Point-of-Care versus Central Laboratory Testing: Accuracy, Reliability, and Clinical Utility for Hematologic, Electrolyte, and Metabolic Parameters The practical advice is to use POCT as a fast complement to, not a replacement for, central lab analysis, and to stick with the same analyzer when tracking a value over time.
Tumor Markers and Their Limits
Tumor markers are proteins or other substances released by cancers or by the body in response to cancers. They are useful but often misunderstood. The most common clinical use is monitoring a known cancer, not diagnosing one from scratch. Rising marker levels can signal a recurrence well before imaging picks anything up, a concept sometimes called biochemical recurrence. The trend over time matters more than any single measurement.27PubMed Central. Tumor markers in clinical practice: General principles and guidelines Tracking the marker’s half-life or doubling time offers a rapid way to judge whether treatment is working.28Clinical Chemistry. Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
False elevations are a constant concern. CEA, a marker used in colorectal and other cancers, can be elevated in smokers, heavy drinkers, and people with liver disease, because a diseased liver clears CEA more slowly. A more exotic pitfall is the “hook effect,” where extremely high concentrations of a marker overwhelm the assay and produce a falsely low reading, the opposite of what you would expect.29PubMed Central. Tumor markers in clinical practice: General principles and guidelines In lung cancer, combining multiple markers improves detection sensitivity for different cancer subtypes. For instance, combining six serum markers pushed the sensitivity for small cell lung carcinoma to 80%, compared with lower figures for any single marker.30iLABMED. Clinical utility of six serum tumor markers for the diagnosis of lung cancer
Therapeutic Drug Monitoring
Some medications have a narrow window between the dose that works and the dose that harms. Clinical chemistry labs measure blood levels of these drugs so that physicians can fine-tune dosing for each patient. Digoxin, a heart medication with a notoriously thin margin of safety, was one of the earliest drugs to be routinely monitored. In a classic study, basing dose adjustments on measured plasma concentrations reduced digoxin toxicity to below 4%.31PubMed Central. Overview of Therapeutic Drug Monitoring The same principle now applies to immunosuppressants given after organ transplants, certain antibiotics, anti-epileptic drugs, and some psychiatric medications. Without these measurements, dosing would rely on guesswork and the hope that a standard dose fits every patient’s metabolism.
Artificial Intelligence in the Lab
AI is beginning to touch every phase of clinical chemistry. In the pre-analytic phase, machine learning models can flag specimens that are hemolyzed, lipemic, or otherwise compromised before they reach the analyzer. In the analytic phase, algorithms can spot instrument drift or calibration shifts. In the post-analytic phase, AI-powered autoverification can release normal results without human review, freeing laboratory staff to focus on abnormal or ambiguous cases.32PubMed. Artificial Intelligence Applications in Clinical Chemistry Some groups are even exploring whether AI can predict certain lab results from a patient’s electronic health record data, potentially reducing unnecessary blood draws. The field is still early enough that most of these tools augment rather than replace human judgment, but the trajectory points toward labs that are substantially leaner and faster than today’s.